-
EP3714038
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3714038
| EP3714038 - CELLULAR COMPOSITIONS AND METHODS OF TREATMENT I [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 28.08.2020 Database last updated on 28.05.2024 | |
| Former | The international publication has been made Status updated on 01.06.2019 | ||
| Former | unknown Status updated on 18.01.2019 | Most recent event Tooltip | 02.10.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states Mesoblast International Sàrl Route de Pre-Bois 20 1217 Meyrin / CH | [2020/40] | Inventor(s) | 01 /
BRINK, Peter c/-505 Fifth Avenue Third Floor New York, NY 10017 / US | 02 /
COHEN, Ira c/-505 Fifth Avenue Third Floor New York, NY 10017 / US | 03 /
LIN, Richard c/-505 Fifth Avenue Third Floor New York, NY 10017 / US | 04 /
DORONIN, Sergey c/-505 Fifth Avenue Third Floor New York, NY 10017 / US | 05 /
POTAPOVA, Irina c/-505 Fifth Avenue Third Floor New York, NY 10017 / US | 06 /
VALIUNAS, Virginijus c/-505 Fifth Avenue Third Floor New York, NY 10017 / US | 07 /
DEVINE, Dan c/-505 Fifth Avenue Third Floor New York, NY 10017 / US | 08 /
SANDRASAGRA, Anthony c/-505 Fifth Avenue Third Floor New York, NY 10017 / US | 09 /
LOIZOS, Nick c/-505 Fifth Avenue Third Floor New York, NY 10017 / US | 10 /
ITESCU, Silviu c/o Level 38 55 Collins Street Melbourne, Victoria 3000 / AU | [2020/40] | Representative(s) | Schnappauf, Georg ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2020/40] | Application number, filing date | 18830515.5 | 21.11.2018 | [2020/40] | WO2018IB01439 | Priority number, date | US201762589764P | 22.11.2017 Original published format: US 201762589764 P | [2020/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019102268 | Date: | 31.05.2019 | Language: | EN | [2019/22] | Type: | A1 Application with search report | No.: | EP3714038 | Date: | 30.09.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.05.2019 takes the place of the publication of the European patent application. | [2020/40] | Search report(s) | International search report - published on: | EP | 31.05.2019 | Classification | IPC: | C12N5/0775, C12N15/113, C12N15/87, A61P35/00 | [2020/40] | CPC: |
C12N15/113 (EP,KR,US);
C12N15/86 (KR);
A61K31/7088 (KR);
A61K35/28 (US);
A61K38/45 (US);
A61P35/00 (KR,US);
C12N5/0663 (EP,KR);
C12N5/0693 (EP,KR);
C12Y204/01214 (US);
C12N15/88 (EP);
C12N2310/11 (US);
C12N2310/14 (EP,KR);
C12N2310/141 (US);
C12N2310/20 (EP);
C12N2320/32 (US);
C12N2501/65 (EP,KR);
C12N2502/1358 (EP);
C12N2510/00 (EP);
C12N2750/14141 (KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/40] | Title | German: | ZELLULÄRE ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG I | [2020/40] | English: | CELLULAR COMPOSITIONS AND METHODS OF TREATMENT I | [2020/40] | French: | COMPOSITIONS CELLULAIRES ET MÉTHODES DE TRAITEMENT I | [2020/40] | Entry into regional phase | 28.05.2020 | National basic fee paid | 28.05.2020 | Designation fee(s) paid | 28.05.2020 | Examination fee paid | Examination procedure | 28.05.2020 | Examination requested [2020/40] | 28.05.2020 | Date on which the examining division has become responsible | 23.12.2020 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 13.11.2020 | Renewal fee patent year 03 | 21.10.2021 | Renewal fee patent year 04 | 13.10.2022 | Renewal fee patent year 05 | 29.09.2023 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Rights in Rem or Legal Means of Execution | ID: | 01 | For: | AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | Date: | 14.01.2022 | [2022/08] | Cited in | International search | [I]WO2005059111 (UNIV COLUMBIA [US], et al) [I] 1-8,12-24,27-31 * claims 1-23 *; | [I]WO2008011133 (UNIV COLUMBIA [US], et al) [I] 1-8,12-24,27-31 * claims 1-28 *; | [I]WO2008141177 (UNIV COLUMBIA [US], et al) [I] 1-8,12-24,27-31 * claims 1-12 *; | [I]WO2010111522 (UNIV CALIFORNIA [US], et al) [I] 1-8,12-24,27-31 * claims 1-67 *; | [I]WO2016086020 (CYTOSTORMRX LLC [US]) [I] 1-8,12-24,27-31 * paragraph [0011] - paragraph [0013]; claim 10 *; | [XI]WO2017165641 (UNIV COLUMBIA [US], et al) [X] 1-3,5-8,12-24,27-31 * pages 33-34, paragraphs 69-70; claims 1-5 * [I] 4; | [A] - BRINK PETER R ET AL, "In vivo cellular delivery of siRNA", I DRUGS: THE INVESTIGATIONAL DRUGS JOURNAL, CURRENT DRUGS LTD, GB, (20100531), vol. 13, no. 6, ISSN 2040-3410, pages 383 - 387, XP009511415 [A] 1-8,12-24,27-31 | [A] - PETER R. BRINK ET AL, "Can gap junctions deliver?", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - BIOMEMBRANES, AMSTERDAM, NL, (20120801), vol. 1818, no. 8, doi:10.1016/j.bbamem.2011.09.025, ISSN 0005-2736, pages 2076 - 2081, XP055559150 [A] 1-8,12-24,27-31 DOI: http://dx.doi.org/10.1016/j.bbamem.2011.09.025 | [A] - L. PEREBOEVA ET AL, "Approaches to Utilize Mesenchymal Progenitor Cells as Cellular Vehicles", STEM CELLS, (20030701), vol. 21, no. 4, doi:10.1634/stemcells.21-4-389, ISSN 1066-6099, pages 389 - 404, XP055559170 [A] 1-8,12-24,27-31 DOI: http://dx.doi.org/10.1634/stemcells.21-4-389 | [A] - LINA RIMKUTE ET AL, "The role of neural connexins in HeLa cell mobility and intercellular communication through tunneling tubes", BMC CELL BIOLOGY, (20160113), vol. 17, no. 1, doi:10.1186/s12860-016-0080-1, XP055559171 [A] 1-8,12-24,27-31 DOI: http://dx.doi.org/10.1186/s12860-016-0080-1 | [A] - SHUO LIU ET AL, "Connexin43 Mediated Delivery of ADAMTS5 Targeting siRNAs from Mesenchymal Stem Cells to Synovial Fibroblasts", PLOS ONE, (20150615), vol. 10, no. 6, doi:10.1371/journal.pone.0129999, page e0129999, XP055559173 [A] 1-8,12-24,27-31 DOI: http://dx.doi.org/10.1371/journal.pone.0129999 | [A] - MIROSLAVA MATUSKOVA ET AL, "Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells : MSC-mediated gene therapy depends on tumour cells properties", JOURNAL OF GENE MEDICINE, US, (20121201), vol. 14, no. 12, doi:10.1002/jgm.2684, ISSN 1099-498X, pages 776 - 787, XP055559184 [A] 1-8,12-24,27-31 DOI: http://dx.doi.org/10.1002/jgm.2684 | by applicant | US5486359 | US5578475 | US6020202 | US6051429 | US6627442 | US6723561 | WO2004085630 | US7615374 | US2014273211 | US9453203 | - J. SAMBROOK et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbour Laboratory Press, (19890000), vol. 1,2 | - Essential Molecular Biology: A Practical Approach, IRL Press, vol. 1, 2 | - DNA Cloning: A Practical Approach, IRL Press, (19950000), vol. 1-4 | - Current Protocols in Immunology, John Wiley & Sons | - BARBERI et al., Plos medicine, (20050000), vol. 2, no. 6, pages 0554 - 0559 | - VODYANIK et al., Cell Stem cell, (20100000), vol. 7, pages 718 - 728 | - OBINATA M., Cell, (19970000), vol. 2, pages 235 - 244 | - AKIMOV et al., Stem Cells, vol. 23, pages 1423 - 1433 | - KABARA et al., Laboratory Investigation, (20140000), vol. 94, pages 1340 - 1354 | - N. E. GOOD; G. D. WINGET; W. WINTER; T N. CONOLLY; S. IZAWA; R. M. M. SINGH, Biochemistry, (19660000), vol. 5, page 467 | - N. E. GOOD; S. IZAWA, Methods Enzymol., (19720000), vol. 24, page 62 | - BADER et al., Gene Ther., (20110000), vol. 18, pages 1121 - 6 | - Essential Molecular Biology: A Practical Approach, IRL Press, (19910000), vol. 1,2 | - "including all updates until present", Current Protocols in Immunology, John Wiley & Sons | - GRIFFITHS-JONES, S., Nucl Acids Res, (20040000), vol. 32, pages D109 - D111 | - KOZOMARA et al., Nucl Acids Res, (20130000), vol. 42, pages D68 - D73 | - LENNOX; BEHLKE, Gene Ther., (20110000), vol. 18, pages 1111 - 20 | - SIMMONS; TOROK-STORB, Blood, (19910000), vol. 78, pages 55 - 62 |